Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection
JD Simmons, CM Stein, C Seshadri, M Campo… - Nature Reviews …, 2018 - nature.com
Mycobacterium tuberculosis is a leading cause of mortality worldwide and establishes a
long-lived latent infection in a substantial proportion of the human population. Multiple lines …
long-lived latent infection in a substantial proportion of the human population. Multiple lines …
Revisiting the timetable of tuberculosis
Revisiting the timetable of tuberculosis Page 1 Revisiting the timetable of tuberculosis OPEN
ACCESS Tuberculosis has a much shorter incubation period than is widely thought, say Marcel …
ACCESS Tuberculosis has a much shorter incubation period than is widely thought, say Marcel …
A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection
Purpose Tuberculosis (TB) remains a common cause of death globally. A regimen of 12
doses of isoniazid (INH) and rifapentine given once weekly (INH/RPT‐3) has recently been …
doses of isoniazid (INH) and rifapentine given once weekly (INH/RPT‐3) has recently been …
Metabolite changes in blood predict the onset of tuberculosis
J Weiner 3rd, J Maertzdorf, JS Sutherland… - Nature …, 2018 - nature.com
New biomarkers of tuberculosis (TB) risk and disease are critical for the urgently needed
control of the ongoing TB pandemic. In a prospective multisite study across Subsaharan …
control of the ongoing TB pandemic. In a prospective multisite study across Subsaharan …
TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings
I Pathmanathan, S Ahmedov, E Pevzner… - … of Tuberculosis and …, 2018 - ingentaconnect.com
Tuberculosis (TB) is the leading cause of death for persons living with the human
immunodeficiency virus (PLHIV). TB preventive therapy (TPT) works synergistically with, and …
immunodeficiency virus (PLHIV). TB preventive therapy (TPT) works synergistically with, and …
Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study
Background In high-incidence settings, recurrent disease among previously treated
individuals contributes substantially to the burden of incident and prevalent tuberculosis …
individuals contributes substantially to the burden of incident and prevalent tuberculosis …
Determinants of tuberculosis trends in six Indigenous populations of the USA, Canada, and Greenland from 1960 to 2014: a population-based study
K Dehghani, Z Lan, P Li, SW Michelsen… - The Lancet Public …, 2018 - thelancet.com
Background Tuberculosis continues to disproportionately affect many Indigenous
populations in the USA, Canada, and Greenland. We aimed to investigate whether …
populations in the USA, Canada, and Greenland. We aimed to investigate whether …
Tackling injustices of occupational lung disease acquired in South African mines: recent developments and ongoing challenges
B Kistnasamy, A Yassi, J Yu, SJ Spiegel, A Fourie… - Globalization and …, 2018 - Springer
Abstract Background South Africa's mineral resources have produced, and continue to
produce, enormous economic wealth; yet decades of colonialism, apartheid, capital flight …
produce, enormous economic wealth; yet decades of colonialism, apartheid, capital flight …
[HTML][HTML] Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
Current diagnostic tests for Mycobacterium tuberculosis (MTB) infection have low prognostic
specificity for identifying individuals who will develop tuberculosis (TB) disease, making …
specificity for identifying individuals who will develop tuberculosis (TB) disease, making …
Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis
More than 10 million new cases of tuberculosis (TB) are diagnosed worldwide each year.
The majority of these cases occur in low‐and middle‐income countries where the TB …
The majority of these cases occur in low‐and middle‐income countries where the TB …